Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
16. Mai 2022 17:00 ET
|
Petros Pharmaceuticals, Inc.
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced financial...
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022
12. Mai 2022 08:13 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
BioCardia Reports First Quarter 2022 Business Highlights and Financial Results
11. Mai 2022 16:15 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
09. Mai 2022 16:05 ET
|
Atossa Therapeutics, Inc.
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and...
Alimera Sciences Reports First Quarter 2022 Results
09. Mai 2022 08:00 ET
|
Alimera Sciences, Inc.
Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021U.S. Net Revenue Increased 23% vs. First Quarter of 2021U.S. End User Demand Up 25% vs. First Quarter of 2021 ATLANTA, May ...